TR-PHARM Sees Early Success In Mediterranean Fever Antibody
Executive Summary
TR-PHARM, a Turkish affiliate of the leading Russian pharma company R-PHARM, has disclosed promising early results for clinical trials with a potential new biologic treatment for familial Mediterranean fever.